Monkeypox Vaccines – Golden Opportunity Or False Dawn?

Moderna, Tonix Pharma Show Interest

While Moderna plans preclinical studies and Tonix Pharma’s candidate is to enter trials in H1, Bavarian Nordic is seeking US and Indian manufacturing partners for its approved monkeypox vaccine. Scrip examines if the disease presents an opportunity for vaccine makers, like COVID-19 did or it could go the H1N1 way

Vial Monkey pox Vaccine
• Source: Shutterstock

Much of the world’s attention over the past few weeks has been captured by monkeypox after its presence in over 90 non-endemic countries pushed the World Health Organization (WHO) to declare a public health emergency of international concern in July.

As health authorities scrambled to control the outbreak, Danish firm Bavarian Nordic A/S, the sole supplier of a monkeypox...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip